PMAH PlasmaTech Inc (CE)

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14C

Information Statement Pursuant to Section 14(c) of the

Securities Exchange Act of 1934

Check the appropriate box:

[ ] Preliminary Information Statement

[ ] Confidential, for Use of the Commission Only (as permitted by

Rule 14c-5(d)(2))

x Definitive Information Statement

PLASMATECH, INC.

(Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box)

x No fee required.

o Fee computed on table below per Exchange Act Rules 14c-5(g) and 0-11.

1) Title of each class of securities to which transaction applies:

2) Aggregate number of securities to which transaction applies:

3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):

4) Proposed maximum aggregate value of transaction:

5) Total fee paid:

o Fee paid previously with preliminary materials.

o Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

1) Amount Previously Paid:

2) Form, Schedule or Registration Statement No.:

3) Filing Party:

4) Date Filed:

[LOGO OF PLASMATECH, INC.]

PLASMATECH, INC.

777 N. Rainbow Boulevard, Suite 250

Las Vegas, Nevada 89107

WE ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.

This Information Statement is first being furnished on or about February 20, 2008 to the holders of record as of the close of business on February 4, 2008 of the common stock of PlasmaTech, Inc. (“PlasmaTech”).

PlasmaTech’s Board of Directors has approved, and a total of 1 stockholder owning 42,000,000 shares of the 70,920,000 shares of common stock outstanding as of February 1, 2008, have consented in writing to the action described below. Such approval and consent constitute the approval and consent of a majority of the total number of shares of outstanding common stock and are sufficient under the Nevada General Corporation Law and PlasmaTech’s Bylaws to approve the action. Accordingly, the action will not be submitted to the other stockholders of PlasmaTech for a vote, and this Information Statement is being furnished to stockholders to provide them with certain information concerning the action in accordance with the requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the regulations promulgated thereunder, including Regulation 14C.

ACTION BY BOARD OF DIRECTORS

AND

CONSENTING STOCKHOLDER

GENERAL

PlasmaTech will pay all costs associated with the distribution of this Information Statement, including the costs of printing and mailing. PlasmaTech will reimburse brokerage firms and other custodians, nominees and fiduciaries for reasonable expenses incurred by them in sending this Information Statement to the beneficial owners of PlasmaTech’s common stock.

PlasmaTech will only deliver one Information Statement to multiple security holders sharing an address unless PlasmaTech has received contrary instructions from one or more of the security holders. Upon written or oral request, PlasmaTech will promptly deliver a separate copy of this Information Statement and any future annual reports and information statements to any security holder at a shared address to which a single copy of this Information Statement was delivered, or deliver a single copy of this Information Statement and any future annual reports and information statements to any security holder or holders sharing an address to which multiple copies are now delivered. You should direct any such requests to the following address: PlasmaTech, Inc., 777 N. Rainbow Boulevard, Suite 250, Las Vegas, Nevada 89107. Attn: Christopher Brough, President. Mr. Brough may also be reach by telephone at (702) 851-1330.

INFORMATION ON CONSENTING STOCKHOLDER

Pursuant to PlasmaTech’s Bylaws and the Nevada General Corporation Act, a vote by the holders of at least a majority of PlasmaTech’s outstanding capital stock is required to effect the action described herein. PlasmaTech’s Articles of Incorporation does not authorize cumulative voting. As of the record date, PlasmaTech had 70,920,000 voting shares of common stock issued and outstanding of which 35,460,001 shares are required to pass any stockholder resolutions. The consenting stockholder, who consist of 1 current stockholder of PlasmaTech, are collectively the record and beneficial owners of 42,000,000 shares, which represents approximately 59.22% of the issued and outstanding shares of PlasmaTech’s common stock. Pursuant to NRS 78.320 of the Nevada General Corporation Act, the consenting stockholder voted in favor of the actions described herein in a joint written consent, dated February 1, 2008. No consideration was paid for the consent. The consenting stockholder’s name, affiliations with PlasmaTech, and his beneficial holdings are as follows:

2